Tech Company Financing Transactions

Rome Therapeutics Funding Round

Rome Therapeutics closed a $77 million Series B financing round on 9/15/2021. Investors included Section 32, Alexandria Venture Investments and Andreessen Horowitz.

Transaction Overview

Company Name
Announced On
9/15/2021
Transaction Type
Venture Equity
Amount
$77,000,000
Round
Series B
Proceeds Purpose
With the support of this group of premier investors, we are well-capitalized and resourced to continue advancing our lead programs into the clinic, expanding our pipeline of repeatome-derived programs and enhancing our repeatomics platform, as we seek to revolutionize the way cancer and autoimmune diseases are treated.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St.
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome -- vast stretches of uncharted genetic material that have long been dismissed as "junk DNA." With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology.
Profile
Rome Therapeutics LinkedIn Company Profile
Social Media
Rome Therapeutics Company Twitter Account
Company News
Rome Therapeutics News
Facebook
Rome Therapeutics on Facebook
YouTube
Rome Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rosana Kapeller
  Rosana Kapeller LinkedIn Profile  Rosana Kapeller Twitter Account  Rosana Kapeller News  Rosana Kapeller on Facebook
Chief Scientific Officer
Dennis Zaller
  Dennis Zaller LinkedIn Profile  Dennis Zaller Twitter Account  Dennis Zaller News  Dennis Zaller on Facebook
Vice President
David Proia
  David Proia LinkedIn Profile  David Proia Twitter Account  David Proia News  David Proia on Facebook
Vice President
Donna Romero
  Donna Romero LinkedIn Profile  Donna Romero Twitter Account  Donna Romero News  Donna Romero on Facebook
VP - Bus. Development
Wenyan Miao
  Wenyan Miao LinkedIn Profile  Wenyan Miao Twitter Account  Wenyan Miao News  Wenyan Miao on Facebook
VP - Finance
Kira Nelson
  Kira Nelson LinkedIn Profile  Kira Nelson Twitter Account  Kira Nelson News  Kira Nelson on Facebook
VP - Operations
Christine Loggins
  Christine Loggins LinkedIn Profile  Christine Loggins Twitter Account  Christine Loggins News  Christine Loggins on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/15/2021: CreatorIQ venture capital transaction
Next: 9/15/2021: Ambi Robotics venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary